In keeping with our previous work, 45 out of 84 pro-fibrotic and pro-inflammatory gene transcript levels associated with IPF were increased significantly in the TGFβ1-treated tissue and 36/45 of these demonstrated a biologically relevant ≥0.5 log2FC increase when compared to control (n = 32 donors). This evidence concerns the gene TGFB1 and idiopathic pulmonary fibrosis.